222 related articles for article (PubMed ID: 11325669)
1. Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; Raffaele J; Tsalamandris C
Am J Kidney Dis; 2001 May; 37(5):890-9. PubMed ID: 11325669
[TBL] [Abstract][Full Text] [Related]
2. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
[TBL] [Abstract][Full Text] [Related]
3. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R
Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
[TBL] [Abstract][Full Text] [Related]
4. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
BMJ; 1991 Jan; 302(6770):210-6. PubMed ID: 1998761
[TBL] [Abstract][Full Text] [Related]
5. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
Laffel LM; McGill JB; Gans DJ
Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
[TBL] [Abstract][Full Text] [Related]
6. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
[TBL] [Abstract][Full Text] [Related]
7. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
Ahmad J; Siddiqui MA; Ahmad H
Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
[TBL] [Abstract][Full Text] [Related]
8. [The effect of perindopril in treatment of early diabetic nephropathy with normal blood pressure and microalbuminuria].
Yao B; Hu G; Li Y; Liao Z; Zhang Y
Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):826-8. PubMed ID: 16206673
[TBL] [Abstract][Full Text] [Related]
9. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
Lancet; 1997 Jun; 349(9068):1787-92. PubMed ID: 9269212
[TBL] [Abstract][Full Text] [Related]
10. Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus.
Kvetny J; Gregersen G; Pedersen RS
QJM; 2001 Feb; 94(2):89-94. PubMed ID: 11181984
[TBL] [Abstract][Full Text] [Related]
11. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
Sjølie AK; Chaturvedi N; Fuller J
Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
[TBL] [Abstract][Full Text] [Related]
12. Long term reduction of microalbuminuria after 1 year of angiotensin converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
Brichard SM; Santoni JP; Thomas JR; van de Voorde K; Ketelslegers JM; Lambert AE
Diabete Metab; 1990; 16(1):30-6. PubMed ID: 2185055
[TBL] [Abstract][Full Text] [Related]
13. The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics.
BENEDICT Group
Control Clin Trials; 2003 Aug; 24(4):442-61. PubMed ID: 12865039
[TBL] [Abstract][Full Text] [Related]
14. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.
Ravid M; Brosh D; Levi Z; Bar-Dayan Y; Ravid D; Rachmani R
Ann Intern Med; 1998 Jun; 128(12 Pt 1):982-8. PubMed ID: 9625684
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
[TBL] [Abstract][Full Text] [Related]
16. PAIT-Survey Follow-Up: Changes in Albuminuria in Hypertensive Diabetic Patients with Mild-Moderate Chronic Kidney Disease.
Fici F; Ari Bakir E; Ilkay Yüce E; Kanuncu S; Makel W; Tarim BA; Robles NR
High Blood Press Cardiovasc Prev; 2020 Feb; 27(1):43-49. PubMed ID: 31916208
[TBL] [Abstract][Full Text] [Related]
17. Renal function, glycemic control and perindopril in diabetic patients.
Brichard S; Ketelslegers JM; Lambert AE
Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
[TBL] [Abstract][Full Text] [Related]
18. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS.
Leoncini G; Martinoli C; Viazzi F; Ravera M; Parodi D; Ratto E; Vettoretti S; Tomolillo C; Derchi LE; Deferrari G; Pontremoli R
Nephron; 2002 Feb; 90(2):169-73. PubMed ID: 11818701
[TBL] [Abstract][Full Text] [Related]
19. Systematic review on urine albumin testing for early detection of diabetic complications.
Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
[TBL] [Abstract][Full Text] [Related]
20. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
Cooper ME
J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]